Thyrocare Technologies Limited has informed the Exchange regarding a press release dated April 23, 2025, titled "On Audited Financial Results for Quarter and year ended March 31, 2025.".
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies Limited has submitted a press release to NSE dated April 23, 2025, covering its audited financial results for the quarter and full year ended March 31, 2025. The filing is a standard regulatory disclosure following the company's board approval of its annual and quarterly results. Specific revenue, profit, and margin figures are not included in the headline excerpt. Shareholders can expect the detailed results, including comparison with the previous year, to be available in the full press release and financial statements on the company's and exchange's website.
This is a routine disclosure announcing audited results, not a new business event. Any meaningful impact on the stock will depend on the actual numbers in the press release versus market expectations and prior-year performance.